Shinva Medical Instrument (600587.SH) subsidiary product obtains Class III medical device registration certificate.
Shinva Medical Instrument (600587.SH) announced that its subsidiary, Shinva Surgical Instruments Co., Ltd., recently received the Medical Device Registration Certificate of the People's Republic of China issued by the National Medical Products Administration. The product names include: plasma surgical equipment, disposable powered linear cutting stapler and staple cartridge, and disposable powered linear cutting stapler and staple cartridge assembly.
Shinva Medical Instrument (600587.SH) announced that its subsidiary, Xinhua Surgical Instruments Co., Ltd., recently received the Medical Device Registration Certificate of the People's Republic of China issued by the National Medical Products Administration. The product names include: plasma surgical equipment, disposable powered linear cutting staplers and staple cartridges, and disposable powered linear cutting stapler and staple cartridge assemblies.
After the plasma surgical equipment is officially launched, it will form deep synergy and efficient matching with the company's existing medical endoscopic camera systems and minimally invasive endoscopic surgical instruments. This not only achieves complementary advantages between equipment and consumable categories, but also expands the service boundaries of the company's overall minimally invasive surgery solutions, enhancing the company's comprehensive competitive strength in the field of minimally invasive surgery. The disposable powered linear cutting staplers and staple cartridge assemblies form synergy with the company's existing minimally invasive endoscopic surgical instrument platform. The certification of these two products enriches the product layout in the field of minimally invasive endoscopic surgery, enhances the company's comprehensive competitive advantage in the field of minimally invasive surgery, and strengthens the company's market coverage capability and brand influence.
Related Articles

SAM WOO CONS (03822) awarded construction engineering contract

Shandong Lukang Pharmaceutical (600789.SH) subsidiary obtains drug registration certificate for Sacubitril Valsartan Sodium Tablets.

HSBC HOLDINGS (00005) spent HKD 93.2413 million to repurchase 580,000 shares on September 21.
SAM WOO CONS (03822) awarded construction engineering contract

Shandong Lukang Pharmaceutical (600789.SH) subsidiary obtains drug registration certificate for Sacubitril Valsartan Sodium Tablets.

HSBC HOLDINGS (00005) spent HKD 93.2413 million to repurchase 580,000 shares on September 21.






